HAVCR2 and neoplasm: The cancer immunoediting framework further reveals that tumor cells drive T cell exhaustion via PD-1, CTLA-4, and Tim-3, characterized by loss of effector function, inhibitory receptor upregulation, and metabolic reprogramming (7–11).